Navigation Links
The ECNP consensus statement on bipolar depression
Date:7/8/2008

Bipolar disorder is one of the most complex and challenging mental disorder in the spectrum. Bipolar disorder is typically associated with considerable acute and longterm treatment needs and may be associated in the course of illness with times of tremendous social burden for both the individual and family. It is typically referred to as an episodic, yet lifelong and clinically severe mood disorder. The disorder is called bipolar, because depressive and manic mood episodes alternate in the course of illness. Because the manic part may be sometimes less impairing and disabling, clinicians differentiate the less severe expression with euphoria and/or extreme irritability called hypomania as Bipolar II as opposed to the more dramatic and severe mania (called Bipolar I disorder).

The long-term course of bipolar disorder is usually dominated by depressive rather than (hypo)manic symptoms, and disease onset tends to be earlier than in patients showing only major depression. A major challenge in the treatment of patients with mood disorders is the distinction between bipolar and unipolar depression from early on, since these conditions may require different types of treatment. Unfortunately, all too often patients with bipolar depression remain untreated or improperly treated. Over the last 10-15 years, there has been an increasing awareness and knowledge about bipolar disorder reflecting the explosion on all fronts in the biomedical literature. Everybody struggles to keep up to.

To take account of the accumulating evidence and experience, the European College of Neuropsychopharmacology (ECNP) recently published a consensus statement that provides an expert summary of state-of-the-art knowledge concerning all aspects of bipolar depression, and broader issues of bipolarity. The highlights of this statement will be presented by the renowned British researcher Guy M. Goodwin from the University Department of Psychiatry, Warneford Hospital, Oxford. The apparent differences between unipolar and bipolar depression arise in diagnosis and epidemiology, bipolar depression in children as well as adults, the use of rating scales, and finally treatment studies to optimize pharmacotherapy and clinical outcome.


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-55734
European College of Neuropsychopharmacology
Source:Eurekalert

Related medicine news :

1. Journal of Ultrasound In Medicine features bioeffects consensus report
2. National Quality Forum Endorses Consensus Standards for Quality of Hospital Care
3. CEOs From Multiple Health Industries Announce Consensus Plan to Reform U.S. Health Care
4. Global Consensus on Mercury: Scientists Defend Science Journalists
5. Curbing worlds most fatal diseases: consensus created by health experts offers global prescription
6. Health Information Exchange Consensus Conference Reinforces Key Role of State-Level Entities
7. Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
8. eHealth Initiative Releases Blueprint Representing Consensus on an Action Plan for Transforming U.S. Healthcare Using Health IT
9. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
10. Blue Cross and Blue Shield Association Statement: Health Care America Now
11. Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror Beauty Boutique ... Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the afternoon ... Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, holding the ...
(Date:9/20/2017)... ... 20, 2017 , ... Announced that Clear Global ... services market) has entered into an agreement on September 1, 2017 with The ... is the first private Dental School to launch an online, accredited Post Graduate ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group ... compliance software, The Guard®, has helped another long-time client pass their Department of ... properly satisfy the law. , Thanks to the help of the Compliancy Group's ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
(Date:8/29/2017)... ivWatch, LLC, the leading provider of continuous monitoring devices for the ... an Innovative Technology contract from Vizient, Inc., the largest member-driven health ... ... detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch based on ...
(Date:8/25/2017)... 2017  Innovation Zed ( www.innovationzed.com ), an Irish medtech company, today ... South Yorkshire and Bassetlaw, England . ... diabetes patients as part of a national NHS Test Bed programme exploring ... Innovation Zed ... InsulCheck Connect, a snap-on accessory for disposable insulin pen users, ...
Breaking Medicine Technology: